Pemetrexed + either carboplatin or oxaliplatin for advanced NSCLC

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxaliplatin plus paclitaxel in advanced NSCLC

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Gemcitabine plus pemetrexed promising in advanced NSCLC

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Cisplatin + pemetrexed as first-line therapy for advanced NSCLC

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 593, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Docetaxel + carboplatin has the edge for advanced NSCLC

By  

Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial

By Gridelli Cesare   Di Maio Massimo  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 321-324

Informa Healthcare

Access to resources Recommend Favorite